Video 7 November 2012

26th IFPMA assembly – panel discussion I


Geneva, October 31, 2012

Panel I: “Innovation Today: Treading New Ground to Meet Global Health Needs”

Cary Adams, CEO, Union for International Cancer Control
Nigel Darby, Vice President of Biotechnologies, Chief Technology Officer GE Healthcare
David Khayat, Professor and Head of Medical Oncology, Pitié-Salpêtrière Hospital
John Lechleiter, Chairman, President, and CEO, Eli Lilly & Company
Mary Lou Valdez, Associate Commissioner for International Programs, U.S. Food and Drug Administration


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.

Learn more

Media Contact

Abigail Jones